Mary J. Roman

Mary J. Roman

Auto-generated profile, based on publicly available information

Mary J. Roman

Weill Cornell Medicine

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2003 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MRMary J. Roman
Mary J. Roman
BSBeth-Ann Shanker
Beth-Ann Shanker
ADAdrienne Davis
Adrienne Davis
MLMichael D. Lockshin
Michael D. Lockshin
LSLisa Sammaritano
Lisa Sammaritano
JSJane E. Salmon
Jane E. Salmon
Although systemic lupus erythematosus is associated with premature myocardial infarction, the prevalence of underlying atherosclerosis and its relation to traditional risk factors for cardiovascular disease and lupus-related factors have not been examined in a case–control study.

1 July 2007 in Hypertension
Verified
Journal Article
Closed access
PDF file
MRMary J. Roman
Mary J. Roman
RDRichard B. Devereux
Richard B. Devereux
JKJorge R. Kizer
Jorge R. Kizer
ELElisa T. Lee
Elisa T. Lee
JGJames M. Galloway
James M. Galloway
BHBarbara V. Howard
Barbara V. Howard
Brachial blood pressure is predictive of cardiovascular outcome; however central pressure may better represent the load imposed on the coronary and cerebral arteries and thereby bear a stronger relationship to vascular damage and prognosis. Relations of brachial and central pressures to carotid artery hypertrophy (intimal-medial thickness and vascular mass), extent of atherosclerosis (plaque score), and incident cardiovascular events were examined in the Strong Heart Study. Central pressures were calculated using radial applanation tonometry. Among 3520 participants, central and brachial pulse pressures were more strongly related to vascular hypertrophy and extent of atherosclerosis than were systolic pressures. Central pulse pressure was more strongly related to all 3 arterial measures than was brachial pulse pressure ( r =0.364 versus 0.309 for plaque score; P <0.001 for comparison of Spearman correlation coefficient; r =0.293 versus 0.249 for intimal-medial thickness; P <0.002; r =0.320 versus 0.289 for vascular mass; P <0.05). Among the 2403 participants free of clinical cardiovascular disease at baseline, 319 suffered fatal or nonfatal cardiovascular events during mean follow-up of 4.8±1.3 years. After adjustment for age, gender, current smoking, body mass index, cholesterol:HDL ratio, creatinine, fibrinogen, diabetes, and heart rate, central pulse pressure predicted cardiovascular events more strongly than brachial pulse pressure (hazards ratio=1.15 per 10 mm Hg, χ 2 =13.4, P <0.001 versus hazards ratio=1.10, χ 2 =6.9, P =0.008). In conclusion, noninvasively-determined central pulse pressure is more strongly related to vascular hypertrophy, extent of atherosclerosis, and cardiovascular events than is brachial blood pressure. These findings support prospective examination of use of central blood pressure as a treatment target in future trials.

1 July 2005 in Hypertension
Verified
Journal Article
Closed access
MRMary J. Roman
Mary J. Roman
RDRichard B. Devereux
Richard B. Devereux
JSJoseph E Schwartz
Joseph E Schwartz
MLMichael D. Lockshin
Michael D. Lockshin
SPStephen A. Paget
Stephen A. Paget
JSJane E. Salmon
Jane E. Salmon
Chronic inflammatory diseases are associated with premature atherosclerosis; however, it is unknown whether arterial stiffness is increased in this setting, possibly as a manifestation of vascular disease preceding and/or independent of atherosclerosis. Carotid ultrasonography and radial applanation tonometry were performed in 101 patients with systemic lupus erythematosus, 80 patients with rheumatoid arthritis, and 105 healthy control subjects. The 3 groups were comparable in age, gender, and carotid artery absolute and relative wall thickness. Atherosclerotic plaque was more common in lupus (46%) and rheumatoid arthritis (38%) patients than in controls (23%) ( P <0.003). Although control subjects had higher central and peripheral blood pressures, arterial stiffness was increased in patient groups compared with controls (lupus, rheumatoid arthritis, controls, respectively: β: 3.36 versus 3.22 versus 2.60, P <0.001; Young’s modulus: 441 versus 452 versus 366 mm Hg/cm, P =0.004; Peterson’s elastic modulus: 278 versus 273 versus 216 mm Hg, P <0.001) after adjustment for differences in mean brachial pressure. In multivariate analysis involving the entire population, arterial stiffness was independently related to age, serum glucose, and the presence of chronic inflammatory disease. In multivariate analysis restricted to the patients, arterial stiffness was independently related to age at diagnosis, disease duration, serum cholesterol, and C-reactive protein (and IL-6, when substituted for C-reactive protein). When analyses were repeated in the 186 study subjects without carotid plaque, arterial stiffness remained significantly elevated in patient groups after adjustment for differences in age and mean brachial pressure. In conclusion, arterial stiffness is increased in chronic inflammatory disorders independent of the presence of atherosclerosis and is related to disease duration, cholesterol, and the inflammatory mediator C-reactive protein and the cytokine that stimulates its production, IL-6.

1 October 2009 in JACC
Verified
Journal Article
Closed access
MRMary J. Roman
Mary J. Roman
RDRichard B. Devereux
Richard B. Devereux
JKJorge R. Kizer
Jorge R. Kizer
POPeter M. Okin
Peter M. Okin
ELElisa T. Lee
Elisa T. Lee
BHBarbara V. Howard
Barbara V. Howard

21 February 2006 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
MRMary J. Roman
Mary J. Roman
EMElfi Moeller
Elfi Moeller
ADAdrienne Davis
Adrienne Davis
SPStephen A. Paget
Stephen A. Paget
MCMary K. Crow
Mary K. Crow
JSJane E. Salmon
Jane E. Salmon
Rheumatoid arthritis is associated with increased morbidity and mortality because of cardiovascular disease, independent of traditional risk factors. To determine the prevalence of preclinical atherosclerosis in patients with rheumatoid arthritis and to identify clinical and biological markers for atherosclerotic disease in this patient population. Matched, cross-sectional study. Hospital for Special Surgery in New York City. 98 consecutive outpatients with rheumatoid arthritis who were followed by rheumatologists and 98 controls matched on age, sex, and ethnicity. Cardiovascular risk factor ascertainment and carotid ultrasonography in all participants; disease severity, disease treatment, and inflammatory markers in patients with rheumatoid arthritis. Despite a more favorable risk factor profile, patients with rheumatoid arthritis had a 3-fold increase in carotid atherosclerotic plaque (44% vs. 15%; P < 0.001). The relationship between rheumatoid arthritis and carotid atherosclerotic plaque remained after accounting for age, serum cholesterol levels, smoking history, and hypertensive status; adjusted predicted prevalence was 7.4% (95% CI, 3.4% to 15.2%) for the control group and 38.5% (CI, 25.4% to 53.5%) for patients with rheumatoid arthritis. Age (P < 0.001) and current cigarette use (P < 0.014) were also significantly associated with carotid atherosclerotic plaque. Among patients with rheumatoid arthritis, atherosclerosis was related to age, hypertension status, and use of tumor necrosis factor-α inhibitors (a possible marker of disease severity). The study had a cross-sectional design, and inflammatory markers were determined only once. Patients with rheumatoid arthritis have a high prevalence of preclinical atherosclerosis independent of traditional risk factors, suggesting that chronic inflammation and, possibly, disease severity are atherogenic in this population.

1 February 2010 in Journal Of Hypertension
Verified
Journal Article
Closed access
MRMary J Roman
Mary J Roman
POPeter M Okin
Peter M Okin
JKJorge R Kizer
Jorge R Kizer
ELElisa T Lee
Elisa T Lee
BHBarbara V Howard
Barbara V Howard
RDRichard B Devereux
Richard B Devereux
Objective We previously demonstrated stronger relations of central vs. brachial blood pressure, particularly pulse pressure, to carotid artery hypertrophy and extent of atherosclerosis. Data regarding the relative impacts of central and brachial pressures on left ventricular hypertrophy and geometry are limited. Methods Echocardiography and radial applanation tonometry were performed in American Indian participants in the 4th Strong Heart Study examination. Left ventricular mass was calculated using an anatomically validated formula and adjusted for height2.7. Brachial blood pressure was measured according to a standardized protocol. Central pressures were derived using a generalized transfer function. Results Of 2585 participants in the analysis, 60% were women, 21% had diabetes and 33% were hypertensive; the mean age was 40 ± 17 years. All blood pressure variables were significantly related to left ventricular absolute and relative wall thicknesses and left ventricular mass index (all P < 0.001), with considerable variation in correlation coefficients (r = 0.135–0.432). Central and brachial systolic pressures were uniformly more strongly related to left ventricular wall thicknesses, diastolic diameter and mass index than their respective pulse pressures (all P < 0.005 by z statistics). Left ventricular relative wall thickness and mass index were more strongly related to central than brachial pressures. Conclusion Left ventricular hypertrophy is more strongly related to systolic pressure than to pulse pressure. Furthermore central pressures are more strongly related than brachial pressures to concentric left ventricular geometry. These data suggest that absolute (systolic) pressure is more important in stimulating left ventricular hypertrophy and remodeling, whereas pulsatile stress (pulse pressure) is more important in causing vascular hypertrophy and atherosclerosis.